Midwives across the world are under growing pressure, with many reporting exhaustion, stress, and a desire to leave the profession. Australia is no exception. A 2024 national review commissioned by the Nursing and Midwifery ...
18 hours ago
0
0
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic disorders. Now, a clinical trial reports that a single dose can significantly improve physical strength ...
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement ...
18 hours ago
0
0
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features. A polygenic risk score (PRS) can capture multiple genetic risk factors to provide an estimate ...
18 hours ago
0
0
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University. Conducted in partnership with ...
18 hours ago
0
0
How can the onset of psychotic symptoms characteristic of schizophrenia be explained? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological mechanisms that precede their ...
19 hours ago
0
1
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be used as a form of treatment, ...
19 hours ago
0
1
Psilocybin is a naturally occurring psychedelic compound that is the active ingredient in certain types of mushrooms (also called magic mushrooms), long used by Indigenous communities in parts of Mexico and Central America ...
A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral suppression and demonstrated ...
20 hours ago
0
0
A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to researchers at UNIST. Led by Professor Joo Hun Kang in the Department of Biomedical Engineering at UNIST, ...
20 hours ago
0
1
